(Q34717709)

4 August 2017

1 reference

title

Gamma hydroxybutyric acid (GHB) intoxication (English)

1 reference

4 August 2017

0 references

Phillip E Mason

1

1 reference

PubMed ID

12093716

4 August 2017

William P Kerns

series ordinal

2

1 reference

4 August 2017

1 July 2002

1 reference

Academic Emergency Medicine

4 August 2017

1 reference

4 August 2017

9

1 reference

4 August 2017

7

1 reference

4 August 2017

730-739

1 reference

GAMMA-HYDROXYBUTYRATE, A NORMAL BRAIN METABOLITE.

4 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

21 January 2018

Sodium 4-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

An EEG-behavioral study of sodium hydroxybutyrate in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

gamma-Hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gammahydroxybutyrate: an endogenous regulator of energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Slow wave sleep and a state resembling absence epilepsy induced in the rat by γ-hydroxybutyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

VARIOUS SEIZURE ACTIVITIES FOLLOWING GAMMA-HYDROXYBUTYRATE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Purification and characterization of an NADP+-linked alcohol oxido-reductase which catalyzes the interconversion of gamma-hydroxybutyrate and succinic semialdehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma-hydroxybutyrate, a possible neurotransmitter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Conversion in vivo of γ-aminobutyric to γ-hydroxybutyric acid in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Significance of gamma-hydroxybutyric acid in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma-hydroxybutyrate promotes oscillatory activity of rat and cat thalamocortical neurons by a tonic GABAB, receptor-mediated hyperpolarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

γ-Hydroxybutyrate hyperpolarizes hippocampal neurones by activating GABAB receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Conversion of gamma-hydroxybutyrate to gamma-aminobutyrate in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Metabolism of [1-14C]γ-hydroxybutyric acid by rat brain after intraventricular injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

The effect of gamma-hydroxybutyric acid on amino acid levels in brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Effects of baclofen and gamma-hydroxybutyrate on rat striatal and mesolimbic 5-HT metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Naloxone pretreatment alters the local cerebral metabolic effect of gamma-hydroxybutyrate in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Naloxone reverses the inhibitory effect of gamma-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Prevalence of drugs used in cases of alleged sexual assault

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

A tale of novel intoxication: seven cases of gamma-hydroxybutyric acid overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Clinical course of gamma-hydroxybutyrate overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

An evaluation of gamma-hydroxybutyric acid in paediatric practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma hydroxybutyrate in the monkey: I. Electroencephalographic, behavioral, and pharmacokinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma hydroxybutyrate. Correlation of serum and cerebrospinal fluid levels with electroencephalographic and behavioral effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma-hydroxybutyrate associated deaths.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Adverse events, including death, associated with the use of 1,4-butanediol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Coma and respiratory depression following the ingestion of GHB and its precursors: three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Ethanol potentiates the toxic effects of 1,4-butanediol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

ynergy of ethanol and a natural soporific--gamma hydroxybutyrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Cross-tolerance to ethanol and gamma-hydroxybutyric acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Successful management of prolonged gamma-hydroxybutyrate and alcohol withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Coma induced by abuse of gamma-hydroxybutyrate (GBH or liquid ecstasy): a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Therapeutic gamma-hydroxybutyric acid monitoring in plasma and urine by gas chromatography-mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Evaluation and development of gas chromatographic procedures for the determination of gamma-hydroxybutyric acid and gamma-butyrolactone in plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma hydroxybutyrate in the monkey: III. Effect of intravenous anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma hydroxybutyrate in the monkey: II. Effect of chronic oral anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma hydroxybutyrate in the monkey IV. Dopaminergic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

3'-5' cyclic-guanosine monophosphate increase in rat brain hippocampus after gamma-hydroxybutyrate administration. Prevention by valproate and naloxone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma-hydroxybutyrate overdose and physostigmine: teaching new tricks to an old drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Butyrolactone-induced central nervous system depression after ingestion of RenewTrient, a "dietary supplement".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

DIFFERENTIAL ESTIMATION OF GAMMA-BUTYROLACTONE AND GAMMA-HYDROXYBUTYRIC ACID IN RAT BLOOD AND BRAIN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma-butyrolactone and gamma-hydroxybutyric acid. II. The pharmacologically active form.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

PRELIMINARY REPORT ON THE METABOLISM OF GAMMA-BUTYROLACTONE AND GAMMA-HYDROXYBUTYRIC ACID.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Evidence that central nervous system depression by 1,4-butanediol in mediated through a metabolite, gamma-hydroxybutyrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

In vivo conversion of gamma-aminobutyric acid and 1,4-butanediol to gamma-hydroxybutyric acid in rat brain. Studies using stable isotopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

"Grievous bodily harm:" gamma hydroxybutyrate abuse leading to a Wernicke-Korsakoff syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma-hydroxybutyrate withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Severe gamma-hydroxybutyrate withdrawal: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Physical dependence on sodium oxybate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma butyrolactone (GBL) withdrawal syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

A case of withdrawal from the GHB precursors gamma-butyrolactone and 1,4-butanediol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

gamma-Hydroxybutyrate withdrawal and chloral hydrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

A case of severe withdrawal from gamma-hydroxybutyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Two cases of withdrawal from 1,4-Butanediol use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2002.TB02154.X

10.1111/J.1553-2712.2002.TB02154.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12093716